{"id":38097,"date":"2022-04-11T13:53:38","date_gmt":"2022-04-11T12:53:38","guid":{"rendered":"https:\/\/www.basilstrategies.com\/?p=38097"},"modified":"2022-04-11T13:53:38","modified_gmt":"2022-04-11T12:53:38","slug":"openfnim-digital-pharma-hadjiat-silber","status":"publish","type":"post","link":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/","title":{"rendered":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat"},"content":{"rendered":"<blockquote><p>Est-ce que les outils de sant\u00e9 digitale peuvent constituer d\u00e9sormais une BU ou business unit des industries du m\u00e9dicament ? C&rsquo;\u00e9tait la question pos\u00e9e lors du dialogue entre Denise Silber, en tant que Secr\u00e9taire-G\u00e9n\u00e9ral de la Fnim et\u00a0 le Dr Yacine Hadjiat, directeur-g\u00e9n\u00e9ral de Biogen monde, \u00e0 l&rsquo;occasion de l&rsquo;Open Fnim. L&rsquo;Open Fnim est une matinale annuelle au cours de laquelle <a href=\"https:\/\/www.lafnim.com\/\">la Fnim<\/a>, association qui f\u00e9d\u00e8re 70+ soci\u00e9t\u00e9s de l&rsquo;information m\u00e9dicale en France, ouvre ses porte aux non-adh\u00e9rents.<\/p><\/blockquote>\n<p>Vous trouverez ci-dessous le replay de l&rsquo;heure d&rsquo;\u00e9change qui a eu lieu \u00e0 Paris \u00e0 l&rsquo;AeroClub le 23 mars, 2022.\u00a0 Quels sont les produits en d\u00e9veloppement chez Biogen ? Comment est-ce que l&rsquo;entit\u00e9 \u00ab\u00a0digital health solutions\u00a0\u00bb est organis\u00e9e ? Le Dr Yacine Hadjiat a expliqu\u00e9 le parcours qui l&rsquo;a conduit de ses \u00e9tudes de m\u00e9decine \u00e0 l&rsquo;industrie pharma \u00ab\u00a0traditionnelle\u00a0\u00bb puis \u00e0 s&rsquo;int\u00e9resser de plus en plus \u00e0 l&rsquo;innovation digitale, ainsi que la vision qu&rsquo;il a d\u00e9velopp\u00e9e et en quoi consiste cette division de Biogen. D\u00e9couvrez le replay ci-dessous !<\/p>\n<p><strong>Le replay commence par l&rsquo;introduction du Pr\u00e9sident de l&rsquo;association, Pierre-Henri Freyssingeas et l&rsquo;interview d\u00e9bute \u00e0 5&rsquo;55\u00a0\u00bb.<\/strong><\/p>\n<div class=\"x-resp-embed x-is-video x-is-youtube\"><iframe loading=\"lazy\" title=\"Replay: \u00ab Le Num\u00e9rique en Sant\u00e9,nouvelle Business Unit Pharma ? \u00bb Open Fnim 2022\" width=\"1184\" height=\"666\" src=\"https:\/\/www.youtube.com\/embed\/RtlQNENBpFI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe><\/div>\n<div id=\"sconnect-is-installed\" style=\"display: none;\"><\/div>\n<div id=\"sconnect-is-installed\" style=\"display: none;\"><\/div>\n<div id=\"sconnect-is-installed\" style=\"display: none;\"><\/div>\n<div id=\"sconnect-is-installed\" style=\"display: none;\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Est-ce que les outils de sant\u00e9 digitale peuvent constituer d\u00e9sormais une BU ou business unit des industries du m\u00e9dicament ? C&rsquo;\u00e9tait la question pos\u00e9e lors du dialogue entre Denise Silber, &#8230; <a href=\"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":38099,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[69,70,71,72,73,74,75,76,77,78],"class_list":["post-38097","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite","tag-denise-silber-fr","tag-digital-pharma-fr","tag-digitalpharma","tag-fnim","tag-hcsmeufr","tag-la-fnim","tag-openfnim","tag-pharma-fr","tag-video","tag-yacine-hadjiat"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies<\/title>\n<meta name=\"description\" content=\"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies\" \/>\n<meta property=\"og:description\" content=\"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/\" \/>\n<meta property=\"og:site_name\" content=\"Basil Strategies\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-11T12:53:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2332\" \/>\n\t<meta property=\"og:image:height\" content=\"1308\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminaccount505\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminaccount505\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/\"},\"author\":{\"name\":\"adminaccount505\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/#\\\/schema\\\/person\\\/b498931a0f4f7480ce1abeb4fb07ce08\"},\"headline\":\"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat\",\"datePublished\":\"2022-04-11T12:53:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/\"},\"wordCount\":229,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test.basilstrategies.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/OpenFnimSilberHadjiat.jpg\",\"keywords\":[\"\\\"denise silber\\\"\",\"digital pharma\",\"digitalpharma\",\"Fnim\",\"hcsmeufr\",\"la Fnim\",\"openfnim\",\"pharma\",\"video\",\"Yacine hadjiat\"],\"articleSection\":[\"actualit\u00e9\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/\",\"url\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/\",\"name\":\"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/test.basilstrategies.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/OpenFnimSilberHadjiat.jpg\",\"datePublished\":\"2022-04-11T12:53:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/#\\\/schema\\\/person\\\/b498931a0f4f7480ce1abeb4fb07ce08\"},\"description\":\"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#primaryimage\",\"url\":\"https:\\\/\\\/test.basilstrategies.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/OpenFnimSilberHadjiat.jpg\",\"contentUrl\":\"https:\\\/\\\/test.basilstrategies.com\\\/wp-content\\\/uploads\\\/2022\\\/04\\\/OpenFnimSilberHadjiat.jpg\",\"width\":2332,\"height\":1308},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/2022\\\/04\\\/11\\\/openfnim-digital-pharma-hadjiat-silber\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/home-2024-2\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/#website\",\"url\":\"https:\\\/\\\/test.basilstrategies.com\\\/\",\"name\":\"Basil Strategies\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/test.basilstrategies.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/test.basilstrategies.com\\\/#\\\/schema\\\/person\\\/b498931a0f4f7480ce1abeb4fb07ce08\",\"name\":\"adminaccount505\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g\",\"caption\":\"adminaccount505\"},\"sameAs\":[\"https:\\\/\\\/test.basilstrategies.com\"],\"url\":\"https:\\\/\\\/test.basilstrategies.com\\\/fr\\\/author\\\/adminaccount505\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies","description":"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies","og_description":"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.","og_url":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/","og_site_name":"Basil Strategies","article_published_time":"2022-04-11T12:53:38+00:00","og_image":[{"width":2332,"height":1308,"url":"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg","type":"image\/jpeg"}],"author":"adminaccount505","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"adminaccount505","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#article","isPartOf":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/"},"author":{"name":"adminaccount505","@id":"https:\/\/test.basilstrategies.com\/#\/schema\/person\/b498931a0f4f7480ce1abeb4fb07ce08"},"headline":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat","datePublished":"2022-04-11T12:53:38+00:00","mainEntityOfPage":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/"},"wordCount":229,"commentCount":0,"image":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#primaryimage"},"thumbnailUrl":"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg","keywords":["\"denise silber\"","digital pharma","digitalpharma","Fnim","hcsmeufr","la Fnim","openfnim","pharma","video","Yacine hadjiat"],"articleSection":["actualit\u00e9"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/","url":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/","name":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat - Basil Strategies","isPartOf":{"@id":"https:\/\/test.basilstrategies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#primaryimage"},"image":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#primaryimage"},"thumbnailUrl":"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg","datePublished":"2022-04-11T12:53:38+00:00","author":{"@id":"https:\/\/test.basilstrategies.com\/#\/schema\/person\/b498931a0f4f7480ce1abeb4fb07ce08"},"description":"La sant\u00e9 digitale en tant que business unit pharma. Interview du Dr Yacine Hadjiat, Biogen par Denise Silber, BasilStrategies.","breadcrumb":{"@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#primaryimage","url":"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg","contentUrl":"https:\/\/test.basilstrategies.com\/wp-content\/uploads\/2022\/04\/OpenFnimSilberHadjiat.jpg","width":2332,"height":1308},{"@type":"BreadcrumbList","@id":"https:\/\/test.basilstrategies.com\/fr\/2022\/04\/11\/openfnim-digital-pharma-hadjiat-silber\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test.basilstrategies.com\/fr\/home-2024-2\/"},{"@type":"ListItem","position":2,"name":"Replay Fnim: Quelle vision pour le digital comme Business Unit en pharma ? Interview du Dr Yacine Hadjiat"}]},{"@type":"WebSite","@id":"https:\/\/test.basilstrategies.com\/#website","url":"https:\/\/test.basilstrategies.com\/","name":"Basil Strategies","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test.basilstrategies.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/test.basilstrategies.com\/#\/schema\/person\/b498931a0f4f7480ce1abeb4fb07ce08","name":"adminaccount505","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/03cd3737560a4c0efda608ac808f4e1a19ea640187e505f41fab70f72ba615a5?s=96&d=mm&r=g","caption":"adminaccount505"},"sameAs":["https:\/\/test.basilstrategies.com"],"url":"https:\/\/test.basilstrategies.com\/fr\/author\/adminaccount505\/"}]}},"_links":{"self":[{"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/posts\/38097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/comments?post=38097"}],"version-history":[{"count":0,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/posts\/38097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/media\/38099"}],"wp:attachment":[{"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/media?parent=38097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/categories?post=38097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test.basilstrategies.com\/fr\/wp-json\/wp\/v2\/tags?post=38097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}